11
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Fusidic Acid Disk Diffusion Testing of Clostridium difficile can be Calibrated Using Single-Strain Regression Analysis

Pages 633-636 | Published online: 08 Jul 2009

REFERENCES

  • Cronberg S, Castor B, Thorén A. Fusidic acid for the treatment of antibiotic-associated colitis induced by Clostridium difficile. Infection 1984; 12: 276–9.
  • Wenisch C, Parschalk B, Hasenhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22: 813–8.
  • Kronvall G, Ringertz S. Antibiotic disk diffusion testing revisited. Single strain regression analysis. APMIS 1991; 99: 295–306.
  • Kronvall G, Holst E. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species. Clin Microbiol Infect 2000; 6: 195–201.
  • Olsson-Liljequist B, Larsson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis ; Suppl 1997; 105: 13–23.
  • Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand Sect B ; Suppl 1971; 217: 1–90.
  • Kronvall G. Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing. J Clin Microbiol 1982; 16: 784–93.
  • Forsberg P, Petersson AC, Kronvall G. Determination of species- and laboratory-related interpretative breakpoints for doxycycline susceptibility testing using single-strain regression analysis. Acta Pathol Microbiol Immunol Scand Sect B 1985; 93: 53–60.
  • Björklind A, Ringertz S, Kronvall G. Types of interpretative errors in susceptibility testing. APMIS 1989; 97: 941–8.
  • Kronvall G, Ringertz S, Karlsson I, Göransson E, Dornbusch K. Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother 1988; 32: 1484–9.
  • Kronvall G, Rylander M, Walder M, et al. Calibration of disk diffusion antibiotic susceptibility testing: species-related trovafloxacin interpretive zone breakpoints and selection of disk potency. Scand J Infect Dis 1999; 31: 573–8.
  • Kronvall G, Petersson AC, Ljunggren K, Soltesz V. Singlestrain regression analysis for quality control of cephalothin-susceptibility testing and determination of interpretive breakpoints. Acta Pathol Microbiol Immunol Scand Sect B 1984; 92: 13–22.
  • Kronvall G. Single strain regression analysis. New method for determination of laboratory- and species-specific interpretive breakpoints for improved accuracy of the disk diffusion antibiotic susceptibility test. In: Spitzy KH, Karrer K, editors. Proceedings of the 13th International Congress of Chemotherapy; 1983; Vienna; 18–21.
  • Soussy C-J, Cluzel R, Courvalin P. Comité de l’Antibiogramme de la Société Francaise de Microbiologie. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. Eur J Clin Microbiol Infect Dis 1994; 13: 238–46.
  • Furtado GL, Medeiros AA. Single-disk diffusion testing (Kirby-Bauer) of susceptibility of Proteus mirabilis to chloramphenicol: significance of the intermediate category. J Clin Microbiol 1980; 12: 550–3.
  • Smith JA, Henry DA, Bourgault AM. Comparison of agar disk diffusion, microdilution broth, and agar dilution for testing antimicrobial susceptibility of coagulase-negative staphylococci. J Clin Microbiol 1987; 25: 1741–6.
  • Toma E, Barriault D. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci. J Clin Microbiol 1995; 33: 1712–5.
  • Coutant C, Olden D, Bell J, Turnidge JD. Disk diffusion interpretive criteria for fusidic acid susceptibility testing of staphylococci by the National Committee for Clinical Laboratory Standards method. Diagn Microbiol Infect Dis 1996; 25: 9–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.